Adverse drug reaction profile of cisplatin-based chemotherapy regimen in a tertiary care hospital in India: An evaluative study

Indian Journal of Pharmacology

Volumn 42, Issue 1, 2010, Pages 40-43

  Surendiran, A ^a   Balamurugan, N ^b   Gunaseelan, K ^a   Akhtar, Shahid ^a   Reddy, K S ^a   Adithan, C ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b NONE

Author keywords

Chemotherapy; Cisplatin; Pharmacovigilance

Indexed keywords

CISPLATIN;

ALGORITHM; ALOPECIA; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; FEMALE; HUMAN; HYPOCALCEMIA; INDIA; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT MONITORING; PROSPECTIVE STUDY; RATING SCALE; TERTIARY HEALTH CARE; THYMOMA; TINNITUS; UTERINE CERVIX CARCINOMA; VOMITING;

EID: 77951692595     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.62412     Document Type: Article

References (29)

1. Adithan C. National pharmacovigilance programme. Indian J Pharmacol 2005;37:347.
2. World Health Organization. Safety monitoring of medicinal products. Guidelines for setting up and running a pharmacovigilance centre. Available from: http://www.who-umc.org/graphics/4807.pdf [last cited on 2008 Dec 31].
3. Aggarwal SK. Calcium modulation of toxicities due to Cisplatin. Met Based Drugs 1998;5:77-81.
4. Drop box. Uppsala Reports. Available from http://www.who-umc.org/ graphics/9628.pdf. [last cited on 2008 Dec 31].
5. O'Brien C. Nausea and vomiting. Can Fam Physician 2008;54:861-3.
6. World Health Organization. Uppsala Monitoring Center. Causality Assessment of Suspected Adverse Reactions. Available from: http://www.who-umc. org/DynPage.aspx?id=22682. [last cited on 2008 Dec 31].
7. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
8. Schumock GT, Thornton J P. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992;27:538.
9. Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992;49:2229-32.
10. Jordan K, Sippel C, Schmoll HJ. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: Past, present, and future recommendations. Oncologist 2007;12:1143-50.
11. Joy J, Nair CK. Amelioration of cisplatin induced nephrotoxicity in Swiss albino mice by Rubia cordifolia extract. J Cancer Res Ther 2008;4:111-5.
12. Fillastre J P, Raguenez-Viotte G. Cisplatin nephrotoxicity. Toxicol Lett 1989;46: 163-75.
13. Sheikh-Hamad D, Timmins K, Jalali Z. Cisplatin-induced renal toxicity: Possible reversal by N-acetylcysteine treatment. J Am Soc Nephrol 1997;8:1640-4.
14. Kaltenbach JA, Rachel JD, Mathog TA, Zhang J, Falzarano PR, Lewandowski M. Cisplatin-induced hyperactivity in the dorsal cochlear nucleus and its relation to outer hair cell loss: Relevance to tinnitus. J Neurophysiol 2002;88:699-714.
15. Macdonald DR. Neurologic complications of chemotherapy. Neurol Clin 1991;9:955-67.
16. Touraine F, Sainte Laudy J, Boumediene A, Ndikumwenayo F, Decroisette C, Melloni B, et al. Investigation of allergic reactions to platinum salts. Rev Mal Respir 2006;23:458-62.
17. Atsmon J, Dolev E. Drug-induced hypomagnesaemia: Scope and management. Drug Saf 2005;28:763-88.
18. Mohammadianpanah M, Omidvari S, Mosalaei A, Ahmadloo N. Cisplatin-induced hypokalemic paralysis. Clin Ther 2004;26:1320-3.
19. Rodriguez M, Solanki DL, Whang R. Refractory potassium repletion due to cisplatin-induced magnesium depletion. Arch Intern Med 1989;149:2592-4.
20. Shibata H. Treatment for the electrolytic disorders in cancer patients. Gan To Kagaku Ryoho 2008;35:2330-3.
21. Maina A, Richiardi G, Danese S, Defabiani E, Giardina G. Symptomatic hypocalcemia and hypomagnesiemia in cisplatinum-based chemotherapy treated patients: Case report. Eur J Gynaecol Oncol 1996;17:281-2.
22. Brousse C, Baumelou E, Mignot L. Hypocalcemia caused by hypomagnesemia during a treatment with cisplatin. Rev Med Interne 1996;17:498.
23. Flake ZA, Scalley RD, Bailey AG. Practical selection of antiemetics. Am Fam Physician 2004;69:1169-74.
24. Warr DG. Chemotherapy-and cancer-related nausea and vomiting. Curr Oncol 2008;15:S4-9.
25. Chadha V, Shenoi SD. Hair loss in cancer chemotherapeutic patients. Indian J Dermatol Venereol Leprol 2003;69:131-2.
26. Bahl A, Sharma DN, Julka PK, Rath GK. Chemotherapy related toxicity in locally advanced non-small cell lung cancer. J Cancer Res Ther 2006;2:14-6.
27. Botchkarev VA. Molecular mechanisms of chemotherapy-induced hair loss. J Investig Dermatol Symp Proc 2003;8:72-5.
28. Yanez JA, Teng XW, Roupe KA, Fariss MW, Davies NM. Chemotherapy induced gastrointestinal toxicity in rats: Involvement of mitochondrial DNA, gastrointestinal permeability and cyclooxygenase-2. J Pharm Pharm Sci 2003;6:308-14.
29. Papiha SS. Genetic variation in India. Hum Biol 1996;68:607-28.